The Results Of Phase III Optitrop-Lung05 Study Of Sacituzumab Tirumotecan (Sac-TMT) Presented As An ASCO Oral Presentation And Simultaneously Published In The Lancet
english health top
(MENAFN - PR Newswire) CHENGDU, China, May 29, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990) announced today that at the 2026 American Society of ... 2026-05-29 23:46:06